NCT04313257

Brief Summary

This study evaluates the effectiveness of the monocular treatment with action video-games in comparison with the occlusion therapy alone in amblyopic patients, and the satisfaction with the different evaluated treatments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 17, 2019

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 8, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 18, 2020

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 16, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 16, 2023

Completed
Last Updated

March 23, 2023

Status Verified

March 1, 2023

Enrollment Period

3.3 years

First QC Date

March 8, 2020

Last Update Submit

March 22, 2023

Conditions

Keywords

Action Video GamesAmblyopia treatment

Outcome Measures

Primary Outcomes (3)

  • Change from baseline visual acuity (VA) at 14 hours , 28 hours , and 42 hours comparing passive occlusion vs active occlusion (with action video games).

    Visual Acuity (VA in logMAR) will be evaluated by E Snellen Test through an Ipad and the app AmblyopiaVA. The AmblyopiaVA test is designed based on the standard protocol for measuring Visual Acuity in children with Amblyopia.The measure will be performed at 2 m.

    Baseline and 14, 28 and 42 hours post treatment.

  • Change from baseline stereopsis (ST) at 14 hours , 28 hours , and 42 hours comparing passive occlusion vs active occlusion (with action video games).

    Stereopsis (ST in logMAR) will be evaluated by a Multiple Random Points test through an Ipad, the app StereoTAB and anaglyphic glasses. The measures will be performed at 50 cm.

    Baseline and 14, 28 and 42 hours post treatment.

  • Change from baseline contrast sensitivity function (CSF) at 14 hours , 28 hours , and 42 hours comparing passive occlusion vs active occlusion (with action video games).

    The effect of treatment on Contrast Sensitivity Function (CSF in logMAR) will be evaluated by ClinicCFS test using sine grids of four different spatial frequencies: 3, 6, 12 and 18 cpd.

    Baseline and 14, 28 and 42 hours post treatment.

Secondary Outcomes (2)

  • Satisfaction assessed by an ordinal questionnaire designed based on the Treatment Satisfaction Questionnaire for Medication (TSQM).

    42 hours

  • Rate of Compliance comparing passive occlusion vs active occlusion (with action video games) assessed by Google Analytics and written questionnaire.

    Baseline and 14h, 28h and 42 hours.

Study Arms (2)

Passive Occlusion

ACTIVE COMPARATOR

This arm will include those participants who will follow a daily occlusive treatment of 2 hours.

Other: Monocular Passive Occlusion

Active Occlusion

EXPERIMENTAL

This arm will include patients who will be treated with monocular therapy with video-games of one hour on a daily regimen.

Other: Monocular Active Occlusion

Interventions

Occlusion treatment of one hour daily with action video game.

Active Occlusion

Occlusion treatment of two hour daily.

Passive Occlusion

Eligibility Criteria

Age4 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 4-10 years old
  • Anisometropic amblyopia
  • Strabismic amblyopia or mixed
  • Interocular visual acuity (VA) difference of at least 0.2 logMAR
  • No history of eye surgery

You may not qualify if:

  • Non-comitant and/or large constant strabismus (\>30 prism diopters)
  • Any ocular pathological condition or nystagmus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laura Asensio Jurado

Barcelona, Spain

Location

Related Publications (4)

  • Bavelier D, Green CS, Pouget A, Schrater P. Brain plasticity through the life span: learning to learn and action video games. Annu Rev Neurosci. 2012;35:391-416. doi: 10.1146/annurev-neuro-060909-152832.

    PMID: 22715883BACKGROUND
  • Li RW, Ngo C, Nguyen J, Levi DM. Video-game play induces plasticity in the visual system of adults with amblyopia. PLoS Biol. 2011 Aug;9(8):e1001135. doi: 10.1371/journal.pbio.1001135. Epub 2011 Aug 30.

    PMID: 21912514BACKGROUND
  • Bediou B, Adams DM, Mayer RE, Tipton E, Green CS, Bavelier D. Meta-analysis of action video game impact on perceptual, attentional, and cognitive skills. Psychol Bull. 2018 Jan;144(1):77-110. doi: 10.1037/bul0000130. Epub 2017 Nov 27.

    PMID: 29172564BACKGROUND
  • Gambacorta C, Nahum M, Vedamurthy I, Bayliss J, Jordan J, Bavelier D, Levi DM. An action video game for the treatment of amblyopia in children: A feasibility study. Vision Res. 2018 Jul;148:1-14. doi: 10.1016/j.visres.2018.04.005. Epub 2018 May 12.

    PMID: 29709618BACKGROUND

MeSH Terms

Conditions

Amblyopia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Laura Asensio Jurado, MsC

    Universitat Politècnica de Catalunya

    PRINCIPAL INVESTIGATOR
  • Marc Argilés Sans, PhD

    Universitat Politècnica de Catalunya

    STUDY DIRECTOR
  • Lluïsa Quevedo i Junyent, PhD

    Universitat Politècnica de Catalunya

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 8, 2020

First Posted

March 18, 2020

Study Start

September 17, 2019

Primary Completion

January 16, 2023

Study Completion

January 16, 2023

Last Updated

March 23, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations